Sangamo Therapeutics Inc. (SGMO)
0.73
-0.09 (-10.98%)
At close: Mar 31, 2025, 11:40 AM
Sangamo Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Revenue | 57.8M | 176.23M | 111.3M | 110.7M | 118.19M | 102.43M | 84.45M | 36.57M | 19.39M | 39.54M | 45.87M | 24.13M | 21.66M | 10.32M | 20.8M | 22.19M | 16.19M | 9.1M | 7.88M | 2.48M | 1.31M | 2.58M | 4.34M | 4.88M | 3.43M | 2.2M | 2.04M | 1.15M | 632K |
| Cost of Revenue | n/a | 221.56M | 12.11M | 9.44M | 180.65M | 145.92M | 114.87M | 65.73M | 65.62M | 67.13M | 56.74M | 36.98M | 31.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.23M | -700K | n/a | n/a | n/a |
| Gross Profit | 57.8M | -45.33M | 99.19M | 101.26M | -62.45M | -43.49M | -30.41M | -29.16M | -46.23M | -27.59M | -10.87M | -12.85M | -10.05M | 10.32M | 20.8M | 22.19M | 16.19M | 9.1M | 7.88M | 2.48M | 1.31M | 2.58M | 4.34M | 4.88M | 8.66M | 2.9M | 2.04M | 1.15M | 632K |
| Operating Income | -103.97M | -274M | -201.28M | -183.34M | -129.55M | -105.18M | -77.15M | -56.36M | -72.56M | -46.86M | -26.78M | -26.71M | -22.2M | -35.82M | -24.93M | -19.4M | -25.38M | -24.77M | -20.73M | -13.75M | -14.65M | -11.77M | -31.57M | -28.44M | -12.48M | -3.9M | -3.46M | -1.34M | -318K |
| Interest Income | 5.86M | 11.1M | 9.43M | 5.35M | 8.78M | 9.76M | 8.26M | n/a | n/a | n/a | n/a | n/a | n/a | 71K | 81K | n/a | 2.23M | 3.22M | 2.41M | 850K | 620K | 752K | 1.37M | 3.19M | 3.56M | n/a | n/a | n/a | n/a |
| Pretax Income | -98.11M | -262.9M | -191.85M | -177.99M | -120.78M | -95.42M | -68.89M | -54.57M | -71.67M | -46.42M | -26.42M | -26.62M | -22.26M | -35.75M | -24.85M | -18.59M | -24.3M | -21.48M | -17.86M | -13.29M | -13.82M | -10.43M | -29.76M | -25.25M | n/a | n/a | n/a | n/a | n/a |
| Net Income | -97.94M | -257.83M | -192.28M | -178.3M | -121.12M | -75.82M | -68.33M | -54.57M | -71.66M | -40.7M | -26.42M | -26.62M | -22.26M | -35.75M | -24.85M | -18.59M | -24.3M | -21.48M | -17.86M | -13.29M | -13.82M | -10.43M | -29.76M | -25.25M | -9.07M | -3.8M | -3.29M | -1.4M | -308K |
| Selling & General & Admin | 44.73M | 61.17M | 62.68M | 63.22M | 67.1M | 61.69M | 46.74M | 27.2M | 26.33M | 19.2M | 15.68M | 13.8M | 12.14M | 14.04M | 12.59M | 12.61M | 10.33M | 8.31M | 7.09M | 4.51M | 4.92M | 3.59M | 4.16M | 4.75M | 4.57M | 1.8M | 1.24M | 797K | 322K |
| Research & Development | 111.52M | 234.06M | 249.9M | 230.82M | 180.65M | 145.92M | 114.87M | 65.73M | 65.62M | 67.2M | 56.74M | 36.98M | 31.71M | 32.1M | 33.15M | 28.98M | 31.23M | 25.56M | 21.53M | 11.42M | 11.05M | 10.19M | 13.36M | 15.51M | 11.35M | 4.3M | 4.26M | 1.7M | 628K |
| Other Expenses | 5.52M | 155.01M | n/a | n/a | n/a | n/a | n/a | n/a | 887K | 431K | 364K | 82K | -66K | 14.04M | n/a | n/a | 10.33M | 8.31M | 7.09M | 4.81M | 4.92M | 4.16M | 22.17M | 13.06M | 9.8M | 2.5M | n/a | n/a | n/a |
| Operating Expenses | 161.77M | 450.24M | 312.58M | 294.04M | 247.74M | 207.61M | 161.6M | 92.93M | 91.95M | 86.39M | 72.42M | 50.78M | 43.85M | 46.14M | 45.74M | 41.59M | 41.56M | 33.87M | 28.61M | 16.23M | 15.96M | 14.35M | 35.54M | 20.26M | 21.15M | 6.8M | 5.5M | 2.5M | 950K |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 139K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 663K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 161.77M | 450.24M | 312.58M | 294.04M | 247.74M | 207.61M | 161.6M | 92.93M | 91.95M | 86.39M | 72.42M | 50.78M | 43.85M | 46.14M | 45.74M | 41.59M | 41.56M | 33.87M | 28.61M | 16.23M | 15.96M | 14.35M | 35.54M | 20.26M | 15.92M | 6.1M | 5.5M | 2.5M | 950K |
| Income Tax | -167K | -5.07M | 429K | 306K | 345K | -19.6M | 8.26M | -1.5M | -14K | -5.72M | -683K | -591K | -660K | -646K | -676K | -815K | -1.07M | -1.42M | -2.18M | -455K | -832K | -1.34M | -1.43M | 9.87M | -3.42M | -100K | 3.29M | 1.4M | 308K |
| Shares Outstanding (Basic) | 201.7M | 174.44M | 154.34M | 144.57M | 134.45M | 112.11M | 96.94M | 78.08M | 70.55M | 69.76M | 67.02M | 55.97M | 52.74M | 50.51M | 45.17M | 42.05M | 40.83M | 37.35M | 32.5M | 25.86M | 25.13M | 24.81M | 24.49M | 23.12M | 17.38M | 6.01M | 5.84M | 5.49M | 5.14M |
| Shares Outstanding (Diluted) | 201.7M | 174.44M | 154.34M | 144.57M | 134.45M | 112.11M | 96.94M | 78.08M | 70.55M | 69.76M | 67.02M | 55.97M | 52.74M | 50.51M | 45.17M | 42.05M | 40.83M | 37.35M | 32.5M | 25.86M | 25.13M | 24.81M | 24.49M | 23.12M | 17.38M | 6.01M | 5.84M | 5.49M | 5.14M |
| EPS (Basic) | -0.49 | -1.48 | -1.25 | -1.23 | -0.9 | -0.68 | -0.7 | -0.7 | -1.02 | -0.58 | -0.39 | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 | -0.6 | -0.58 | -0.55 | -0.51 | -0.55 | -0.42 | -1.22 | -1.09 | -0.52 | -0.63 | -0.56 | -0.26 | -0.06 |
| EPS (Diluted) | -0.49 | -1.48 | -1.25 | -1.23 | -0.9 | -0.68 | -0.7 | -0.7 | -1.02 | -0.58 | -0.39 | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 | -0.6 | -0.58 | -0.55 | -0.51 | -0.55 | -0.42 | -1.22 | -1.09 | -0.52 | -0.63 | -0.56 | -0.26 | -0.06 |
| EBITDA | -89.09M | -87.43M | -189.17M | -173.9M | -123.87M | -101.25M | -74.79M | -54.86M | -70.67M | -45.8M | -26.23M | -26.08M | -21.54M | -35.1M | -24.18M | -18.83M | -24.85M | -24.77M | -20.73M | -13.26M | -13.38M | -9.6M | -27.89M | -11.07M | -7.25M | -3.2M | -3.46M | -1.34M | -318K |
| Depreciation & Amortization | 9.36M | 22.19M | 12.11M | 9.44M | 5.68M | 3.93M | 2.36M | 1.5M | 997K | 988K | 549K | 569K | 660K | 646K | 676K | 572K | 523K | -1.87M | -686K | 488K | 1.48M | 2.17M | 2.51M | 4.31M | 5.23M | 700K | n/a | n/a | n/a |